-
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages
ソース: Buzz FX / 06 1 2025 02:30:14 America/Chicago
BridgeBio Pharma, Inc. (NASDAQ:BBIO) Receives Consensus Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat January 6, 2025 Share Link copied to clipboard. BridgeBio Pharma, Inc. ( NASDAQ:BBIO - Get Free Report ) has been
Read more...